Jane Street’s Anavex Life Sciences AVXL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$163K Buy
+17,681
New +$163K ﹤0.01% 4832
2025
Q1
Sell
-104,697
Closed -$1.12M 5593
2024
Q4
$1.12M Buy
104,697
+42,282
+68% +$454K ﹤0.01% 2788
2024
Q3
$355K Sell
62,415
-119,531
-66% -$679K ﹤0.01% 4696
2024
Q2
$768K Buy
181,946
+137,046
+305% +$578K ﹤0.01% 4032
2024
Q1
$229K Sell
44,900
-67,410
-60% -$343K ﹤0.01% 4912
2023
Q4
$1.05M Buy
112,310
+30,059
+37% +$280K ﹤0.01% 3271
2023
Q3
$539K Sell
82,251
-352,041
-81% -$2.31M ﹤0.01% 3528
2023
Q2
$3.53M Buy
434,292
+413,231
+1,962% +$3.36M ﹤0.01% 1816
2023
Q1
$180K Buy
21,061
+7,293
+53% +$62.5K ﹤0.01% 4733
2022
Q4
$127K Sell
13,768
-8,352
-38% -$77.3K ﹤0.01% 4605
2022
Q3
$228K Buy
22,120
+3,123
+16% +$32.2K ﹤0.01% 4442
2022
Q2
$190K Sell
18,997
-72,806
-79% -$728K ﹤0.01% 4479
2022
Q1
$1.13M Sell
91,803
-60,333
-40% -$743K ﹤0.01% 2807
2021
Q4
$2.64M Sell
152,136
-51,953
-25% -$901K ﹤0.01% 1632
2021
Q3
$3.66M Sell
204,089
-1,361
-0.7% -$24.4K ﹤0.01% 1216
2021
Q2
$4.7M Buy
205,450
+124,941
+155% +$2.86M ﹤0.01% 983
2021
Q1
$1.2M Buy
80,509
+70,078
+672% +$1.05M ﹤0.01% 2297
2020
Q4
$57K Sell
10,431
-43,612
-81% -$238K ﹤0.01% 3722
2020
Q3
$246K Buy
+54,043
New +$246K ﹤0.01% 3049
2019
Q3
Sell
-142,349
Closed -$480K 3404
2019
Q2
$480K Buy
142,349
+129,673
+1,023% +$437K ﹤0.01% 2315
2019
Q1
$39K Buy
+12,676
New +$39K ﹤0.01% 3161
2018
Q3
Sell
-59,805
Closed -$157K 3454
2018
Q2
$157K Buy
+59,805
New +$157K ﹤0.01% 2981
2017
Q2
Hold
0
2814
2017
Q1
Hold
0
2724
2016
Q2
Sell
-10,047
Closed -$49K 2580
2016
Q1
$49K Sell
10,047
-129,559
-93% -$632K ﹤0.01% 2473
2015
Q4
$778K Buy
+139,606
New +$778K ﹤0.01% 1242